NASDAQ:BRKR - Bruker Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$42.31 +0.22 (+0.52 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$42.31
Today's Range$42.28 - $43.39
52-Week Range$26.10 - $44.47
Volume670,060 shs
Average Volume727,017 shs
Market Capitalization$6.63 billion
P/E Ratio30.22
Dividend Yield0.38%
Beta1.44
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.90 billion
Cash Flow$1.85 per share
Book Value$5.88 per share

Profitability

Net Income$179.70 million

Miscellaneous

Employees6,870
Market Cap$6.63 billion
Next Earnings Date8/1/2019 (Estimated)
OptionableOptionable

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Friday, May 10th. Shareholders of record on Monday, June 3rd will be given a dividend of $0.04 per share on Friday, June 21st. This represents a $0.16 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date is Friday, May 31st. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker announced that its Board of Directors has initiated a stock repurchase plan on Sunday, June 4th 2017, which allows the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company's board believes its shares are undervalued.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) announced its quarterly earnings data on Thursday, May, 2nd. The medical research company reported $0.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.04. The medical research company earned $461.40 million during the quarter, compared to analyst estimates of $450.46 million. Bruker had a return on equity of 26.28% and a net margin of 9.53%. The business's revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.24 earnings per share. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for Bruker.

What guidance has Bruker issued on next quarter's earnings?

Bruker updated its FY19 earnings guidance on Thursday, May, 2nd. The company provided earnings per share guidance of $1.57-1.61 for the period, compared to the Thomson Reuters consensus estimate of $1.57.

What price target have analysts set for BRKR?

7 brokerages have issued 12 month price targets for Bruker's stock. Their predictions range from $32.00 to $53.00. On average, they expect Bruker's share price to reach $44.6667 in the next twelve months. This suggests a possible upside of 5.6% from the stock's current price. View Analyst Price Targets for Bruker.

What is the consensus analysts' recommendation for Bruker?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 1 hold rating, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.

Has Bruker been receiving favorable news coverage?

Media coverage about BRKR stock has been trending positive on Saturday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bruker earned a daily sentiment score of 2.5 on InfoTrie's scale. They also gave news stories about the medical research company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next few days.

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include Mattel (MAT), General Electric (GE), Ultra Clean (UCTT), Twitter (TWTR), New York Times (NYT), US Foods (USFD), American National BankShares (AMNB), Enterprise Bancorp (EBTC), CLEAR CHANNEL O/SH (CCO) and General Motors (GM).

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
  • Dr. Falko Busse, Exec. Officer (Age 52)

Who are Bruker's major shareholders?

Bruker's stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (3.45%), BlackRock Inc. (3.34%), Acadian Asset Management LLC (2.69%), Janus Henderson Group PLC (2.10%), AJO LP (1.42%) and AQR Capital Management LLC (1.09%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Marc A Kastner, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker.

Which major investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Goldman Sachs Group Inc., Marshall Wace LLP, AQR Capital Management LLC, Wells Fargo & Company MN, BlackRock Inc., Morgan Stanley and Voya Investment Management LLC. View Insider Buying and Selling for Bruker.

Which major investors are buying Bruker stock?

BRKR stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Acadian Asset Management LLC, Marshall Wace North America L.P., AJO LP, Robeco Institutional Asset Management B.V., Geode Capital Management LLC, Renaissance Technologies LLC and MERIAN GLOBAL INVESTORS UK Ltd. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $42.31.

How big of a company is Bruker?

Bruker has a market capitalization of $6.63 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.

What is Bruker's official website?

The official website for Bruker is http://www.bruker.com/.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (NASDAQ BRKR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  558 (Vote Outperform)
Underperform Votes:  606 (Vote Underperform)
Total Votes:  1,164
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel